Stay updated with breaking news from Sight Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating) was up 5.5% during mid-day trading on Monday . The stock traded as high as $10.89 and last traded at $10.55. Approximately 58,082 shares traded hands during mid-day trading, a decline of 53% from the average daily volume of 122,836 shares. The stock had previously closed at $10.00. […]
Sight Sciences, Inc. (NASDAQ:SGHT – Get Rating) shares shot up 5.5% during mid-day trading on Monday . The company traded as high as $10.89 and last traded at $10.55. 58,082 shares changed hands during trading, a decline of 53% from the average session volume of 122,836 shares. The stock had previously closed at $10.00. Sight […]
SAN DIEGO — It may be time for a new approach to initial and stepwise interventional therapy in glaucoma, according to a speaker here.
MENLO PARK, Calif., May 06, 2023 -- Sight Sciences, Inc. , an eyecare technology company focused on developing and commercializing innovative technology that enables procedures intended to improve... | May 6, 2023
Sight Sciences (NASDAQ:SGHT – Get Rating) and Invo Bioscience (OTCMKTS:IVOB – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Insider and Institutional Ownership 50.2% of Sight Sciences shares […]